We therefore hypothesized that a sialylated microenvironment containing tp53-mutation-harboring, tumor-prone cells would promote an abundance of SA-utilizing dysbiotic pathobionts and elicit a pro-inflammatory response that would ultimately lead to cancer development. The gene discussed is TP53; the disease is cancer.